Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keizo Koide is active.

Publication


Featured researches published by Keizo Koide.


American Heart Journal | 1968

Experimental and clinical study on the lymph circulation

Kiyoshi Seki; Yoshiji Yamane; A. Shinoura; Keizo Koide; M. Uechi; Kazuo Mori; M. Nagasaka; Yawara Yoshitoshi

Abstract 1. 1. Molecular weight, shape, and electric charge may each play some role in determining the rate of disappearance of macromolecules from subcutaneous connective tissue. 2. 2. The state of the connective tissue, especially the volume and state of its ground substance, may modify the rate of disappearance of macromolecules from the tissue. 3. 3. There are at least three types of edema: tissue clearance of albumin was slow in lymphedema, normal in myxedema, and accelerated in other types of edema. The clearance rate was usually normal in scleroderma and rapid in hyperthyroidism and in edema of lymphosarcomatosis. 4. 4. The rate of clearance of albumin from subcutaneous tissue can be used as an indicator of lymphatic flow under usual conditions.


Therapeutic Apheresis and Dialysis | 2006

Prognostic Factors for a Composite End‐Point of Renal Outcomes in Patients With Chronic Kidney Disease

Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Shozo Koshikawa; Keizo Koide; Kiyoshi Kurokawa

Abstract:  We aimed to investigate prognostic factors for a composite end‐point of end‐stage renal disease (ESRD) and the progression of renal disease in Japanese patients with chronic renal disease. Using a composite end‐point comprising a doubling of serum creatinine (sCr), an increase in sCr level to 6.0 mg/dL, or initiation of dialysis and renal transplantation caused by ESRD, we examined data obtained in a prospective cohort study. The present study consisted of 641 patients who were 20 years of age or older with chronic renal disease caused by diabetic nephropathy, glomerulonephritis, or nephrosclerosis, and who had baseline sCr levels of 5.0 mg/dL or less. The following criteria were examined as prognostic factors: sex; age; elapsed time from initial diagnosis; disease underlying the nephropathy (diabetic or non‐diabetic); complications with hypertension, hyperlipidemia, or anemia; baseline sCr level; therapeutic regimen, including use of ACE inhibitors or Ca2+‐channel blockers; and diet. A log‐rank test was used for univariate analysis, and Cox regression analysis was used for multivariate analysis. Underlying disease (diabetic or non‐diabetic), baseline sCr level, and Ca2+‐channel blocker therapy were significantly related to event incidence. In the present study, we identified underlying disease and baseline sCr level as important prognostic factors for a composite end‐point in a predialysis patient population in both the early and middle stages of renal disease. These factors should be considered as balancing variables for randomization in future clinical studies.


American Journal of Kidney Diseases | 2003

Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF

Tsutomu Sanaka; Kumiko Fujimoto; Jun Niwayama; Hideki Nishimura; Takashi Naito; Chieko Higuchi; Tadao Akizawa; Keizo Koide; Shozo Koshikawa


Japanese Heart Journal | 1960

Congenital Aneurysm of the Right Coronary Sinus of Valsalva with Rupture into the Left Ventricle

Sadataka Tasaka; Yawara Yoshitoshi; Kiyoshi Seki; Keizo Koide; Etsuro Ogata; Kozo Nakamura


Journal of Japanese Society for Dialysis Therapy | 1987

Clinical evaluation of FUT-175 as a regional anti-coagulant in hemodialysis

Shozo Koshikawa; Tadao Akizawa; Kazuo Ota; Mutsuyoshi Kazama; Nobuhide Mimura; Yoshihei Hirasawa; Eiichi Chiba; Hiroshi Sekino; Hitoshi Ueda; Hisashi Takahashi; Yasunori Kitamoto; Hiroshi Kaneda; Noriaki Matsui; Yasushi Asano; Kaoru Tabei; Shinji Naganuma; Keizo Koide; Junko Toyama; Kazumichi Nakamura; Takashi Sekiguchi; Yoshio Suzuki; Takuo Sasaoka; Kiyoshi Ozawa; Fumiaki Marumo; Yusuke Tsukamoto; Hideo Hidai; Masaaki Arakawa; Yasushi Suzuki; Sachio Takahashi; Kenji Maeda


Journal of Japanese Society for Dialysis Therapy | 1982

Therapy prior to hemodialysis

Keizo Koide; Junko Toyama; Noboru Inoue; Shozo Koshikawa; Tadao Akizawa; Ken Takahashi; Saburo Hidaka; Masao Tadokoro; Yoshiji Yamane; Yamazaki Z


Journal of Japanese Society for Dialysis Therapy | 1987

A study of one time a week hemodialysis

Junko Toyama; Keizo Koide


Japanese Journal of National Medical Services | 1985

Significance of serum alkali-phosphatase in renal secondary hyperparathyroidism.

Toru Isomoto; Junko Toyama; Keizo Koide; Shuji Hirose; Sanae Ota; Haruo Funaki


Rinsho Yakuri\/japanese Journal of Clinical Pharmacology and Therapeutics | 1979

Clinical Efficacy of Furosemide-Retard (Hoe 058 R) in Essential Hypertension

Teiryo Maeda; Yoshiaki Masuyama; Shozo Koshikawa; Teizo Sanjyo; Akio Ebihara; Tsuneji Nagai; Teizo Ito; Takao Ikeda; Masashi Ishida; Tadashi Itokawa; Keizo Koide; Tetsugo Sakata; Takuo Sasaoka; Masayoshi Shibagaki; Toshiro Shibata; Katsutaka Seta; Sho Tanaka; Masao Takahashi; Toshio Harada; Saburo Hidaka; Ippei Fujimori; Yo Yamagata; Yoshiji Yamane; Osamu Yokota


Neurologia Medico-chirurgica | 1964

31. Studies on Brain Edema (The third report)

Yawara Yoshitoshi; Kiyoshi Seki; Yoshiji Yamane; Keizo Koide; Kazuo Mori; Masami Yamanaka; Hiroshi Oka; Teizo Sanjyo; Yasuo Endo

Collaboration


Dive into the Keizo Koide's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuo Sasaoka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge